Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.

MLA

Menko, Fred, et al. “Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Renal Cancer Risk, Surveillance and Treatment.” Familial Cancer, vol. 13, no. 4, Dec. 2014, pp. 637–44. EBSCOhost, https://doi.org/10.1007/s10689-014-9735-2.

APA

Menko, F., Maher, E., Schmidt, L., Middelton, L., Aittomäki, K., Tomlinson, I., Richard, S., & Linehan, W. (2014). Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Familial Cancer, 13(4), 637–644. https://doi.org/10.1007/s10689-014-9735-2

Chicago

Menko, Fred, Eamonn Maher, Laura Schmidt, Lindsay Middelton, Kristiina Aittomäki, Ian Tomlinson, Stéphane Richard, and W. Linehan. 2014. “Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Renal Cancer Risk, Surveillance and Treatment.” Familial Cancer 13 (4): 637–44. doi:10.1007/s10689-014-9735-2.